🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Experimental Treatment Gaining Popularity Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these profiles privately for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and claims of rapid UK delivery. Sellers market the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Voice Worries

Nevertheless, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in users administering substances of uncertain source.

Several experts said the demand for the experimental drug could be connected to the increasing cost of approved slimming products such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.

Some influencers try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach medicines, advertising, and consumer regulations, potentially leading to fines, prosecution or prison.

Service Reaction and Content Removal

According to the social media company, the service has taken down problematic material and banned related hashtags and query recommendations. The organization stated it was dedicated to keeping the platform safe and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Investigations also found groups with up to 9,000 participants marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly displays channels with thousands of users, filled with photos of weight loss, glowing testimonials and detailed guides for mixing or injecting at residence.

After moments of joining one group, a vendor shared contact information, where most transactions occur. The vendor sent an instruction manual and promised shipping within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about weight, health issues or previous experience.

Product Details and Costs

Inside these communities, messages show black plastic packages with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled pens typically priced at £160 for 20mg. When asked how long a injector should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for Telegram stated it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they cannot confirm. Even if the science behind this drug is sound, these online versions may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has previously seen individuals injured by personal administration from unverified sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company experimental product not yet approved … may expose patients to possibly significant medical dangers”.